From Surf Wiki (app.surf) — the open knowledge base
Glucose clamp technique
| Field | Value | |
|---|---|---|
| Name | Glucose clamp technique | |
| Image | ||
| Caption | ||
| ICD10 | ||
| ICD9 | ||
| MeshID | D015309 | |
| OtherCodes |
NOTOC Name = Glucose clamp technique | Image = | Caption = | ICD10 = | ICD9 = | MeshID = D015309 | OtherCodes = | Glucose clamp technique is a method for quantifying insulin secretion and resistance. It is used to measure either how well an individual metabolizes glucose or how sensitive an individual is to insulin.
Procedure
Two types of clamp are quite commonly used. The hyperglycemic clamp, which requires maintaining a high blood sugar level by perfusion or infusion with glucose, is a way to quantify how fast beta-cells respond to glucose. The hyperinsulinemic clamp, which requires maintaining a high insulin level by perfusion or infusion with insulin, is a way to quantify how sensitive the tissue is to insulin. The hyperinsulinemic clamp is also called euglycemic clamp, meaning a normal blood sugar level is maintained.
Hyperglycemic clamp technique: The plasma glucose concentration is acutely raised to 125 mg/dl above basal levels by a continuous infusion of glucose. This hyperglycemic plateau is maintained by adjustment of a variable glucose infusion, based on the rate of insulin secretion and glucose metabolism. Because the plasma glucose concentration is held constant, the glucose infusion rate is an index of insulin secretion and glucose metabolism. The hyperglycemic clamps are often used to assess insulin secretion capacity.
Hyperinsulinemic-euglycemic clamp technique: The plasma insulin concentration is acutely raised and maintained at 100 μU/ml by a continuous infusion of insulin. Meanwhile, the plasma glucose concentration is held constant at basal levels by a variable glucose infusion. When the steady-state is achieved, the glucose infusion rate equals glucose uptake by all the tissues in the body and is therefore a measure of tissue insulin sensitivity. The hyperinsulinemic clamps are often used to measure insulin resistance.
History
The glucose clamp technique was developed by University of Texas (UT) School of Medicine Professors DeFronzo, Andres and Tobin in 1979. It has since been the gold standard for pharmacodynamic studies in diabetes drug development and diagnostics evaluation. In human clinical trials, manual glucose clamps as well as the more modern method of automated glucose clamp find common use.
References
References
- Linda von Wartburg, “What's a Glucose Clamp, Anyway?” Diabetes Health. Nov 7, 2007.[http://www.diabeteshealth.com/read/2007/11/06/5500/whats-a-glucose-clamp-anyway/] {{Webarchive. link. (2010-01-31)
- DeFronzo RA, Tobin JD, Andres R. “Glucose Clamp Technique: a Method for Quantifying Insulin Secretion and Resistance.” Am. J. Physiol. 1979, 237, E214–E223.[https://www.ncbi.nlm.nih.gov/pubmed/382871]
- Marcus Hompesch and Klaus Rave. “An Analysis of How to Measure Glucose during Glucose Clamps: Are Glucose Meters Ready for Research?” J. Diabetes Sci. Technol. 2008, 2, 896–898.[http://www.jdst.org/Journal/pdf/September2008/VOL-2-5-CLA3-HOMPESCH.pdf]
- GmbH, Profil Institut für Stoffwechselforschung. "ClampArt and other glucose clamps at Profil".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Glucose clamp technique — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report